Survival analysis between different treatment strategies of mixed adenoneuroendocrine carcinoma (MANEC): a population-based study
Authors:
Open Access
- 5 February 2025
- journal article
- Published by Bioscientifica in Endocrine Connections
- Vol. 14 (3)
Abstract
Background: Mixed adenoneuroendocrine carcinoma (MANEC) is rare and heterogeneous. Currently, there is no concise treatment standard for MANEC. This study aimed to explore the prognostic impact of different treatment methods in MANEC. Methods: The surveillance, epidemiology and end results database was utilized to evaluate the outcomes of MANEC using propensity score matching (PSM) , stratified and site-specific survival analysis. Results: A total of 935 patients diagnosed with MANEC were enrolled in this study. Across most analyses, surgery performance (compared with no surgery) was associated with improved survival outcomes for MANEC patients, except for the site-specific analysis of small intestine, in which no significant association between surgery and patients’ survival was found. Radiotherapy exhibited no significant association with patients’ survival in most cases, and associated with poor prognosis of MANEC in certain specific analyses. Inconsistent effects of chemotherapy on MANEC were observed. Positive impact of chemotherapy on MANEC was indicated in PSM for chemotherapy or radiotherapy. Contradictory effects of chemotherapy were suggested based on the stage of MANEC, with unfavorable outcomes in early-stage and favorable outcomes in advanced-stage. The impact of chemotherapy on survival was influenced by the administration of surgery or radiotherapy. Site-specific analyses indicated that chemotherapy was beneficial to MANEC of the hepatic–biliary–pancreatic system. Conclusions: The results of this study demonstrate the variable impact of different treatment strategies for MANEC. Surgery was generally associated with improved survival outcomes, while radiotherapy did not show a beneficial effect on MANEC. The effects of chemotherapy on MANEC were inconsistent in specific analyses.Keywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515140159)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515010448)
- Dongguan Science and Technology Bureau (20231800940582)
- Dongguan Science and Technology Bureau (20231800936042)
- Discipline construction project of Guangdong Medical University (4SG24029G)
- Talent Development Foundation of The First Dongguan Affiliated Hospital of Guangdong Medical University (PF100-2-03)
This publication has 29 references indexed in Scilit:
- Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?Critical Reviews in Oncology/Hematology, 2023
- European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinomaJournal of Neuroendocrinology, 2023
- An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN)Current Treatment Options in Oncology, 2022
- Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: A systematic review with Bayesian hierarchical survival analysisEuropean Journal of Surgical Oncology, 2021
- The 2019 WHO classification of tumours of the digestive systemHistopathology, 2019
- Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort studyEuropean Journal of Surgical Oncology, 2018
- The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survivalOral Oncology, 2017
- In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma componentsLaboratory Investigation, 2017
- Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of NeoplasmsEndocrine Pathology, 2016
- Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumorHuman Pathology, 2015